International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version for ;2019-covid-expanded
Chapter VI
Diseases of the nervous system
(G00-G99)
G70
Myasthenia
gravis and other myoneural disorders
-
Excl.:
-
botulism (A05.1)
-
transient neonatal myasthenia gravis (P94.0)
-
Coding-Hint
-
Use additional external cause code (Chapter XX), if desired, to
identify drug, if drug-induced.
G70.1
Toxic myoneural disorders
-
Coding-Hint
-
Use additional external cause code (Chapter XX), if desired, to
identify toxic agent.
G70.2
Congenital and developmental myasthenia
G70.8
Other specified myoneural disorders
G70.9
Myoneural disorder, unspecified
G71
Primary
disorders of muscles
-
Excl.:
-
arthrogryposis multiplex congenita (Q74.3)
-
metabolic disorders (E70-E90)
-
myositis (M60.-)
-
Incl.:
-
Muscular dystrophy:
-
autosomal recessive, childhood type, resembling Duchenne or
Becker
-
benign [Becker]
-
benign scapuloperoneal with early contractures
[Emery-Dreifuss]
-
distal
-
facioscapulohumeral
-
limb-girdle
-
ocular
-
oculopharyngeal
-
scapuloperoneal
-
severe [Duchenne]
-
Excl.:
-
congenital muscular dystrophy:
-
NOS (G71.2)
-
with specific morphological abnormalities of the muscle
fibre (G71.2)
-
Incl.:
-
Dystrophia myotonica [Steinert]
-
Myotonia:
-
chondrodystrophic
-
drug-induced
-
symptomatic
-
Myotonia congenita:
-
NOS
-
dominant [Thomsen]
-
recessive [Becker]
-
Neuromyotonia [Isaacs]
-
Paramyotonia congenita
-
Pseudomyotonia
-
Coding-Hint
-
Use additional external cause code (Chapter XX), if desired, to
identify drug, if drug-induced.
G71.2
Congenital myopathies
-
Incl.:
-
Congenital muscular dystrophy:
-
NOS
-
with specific morphological abnormalities of the muscle
fibre
-
Disease:
-
central core
-
minicore
-
multicore
-
Fibre-type disproportion
-
Myopathy:
-
myotubular (centronuclear)
-
nemaline
G71.3
Mitochondrial myopathy, not elsewhere classified
G71.8
Other primary disorders of muscles
G71.9
Primary disorder of muscle, unspecified
-
Incl.:
-
Hereditary myopathy NOS
-
Excl.:
-
arthrogryposis multiplex congenita (Q74.3)
-
dermatopolymyositis (M33.-)
-
ischaemic infarction of muscle (M62.2)
-
myositis (M60.-)
-
polymyositis (M33.2)
G72.0
Drug-induced myopathy
-
Coding-Hint
-
Use additional external cause code (Chapter XX), if desired, to
identify drug.
G72.2
Myopathy due to other toxic agents
-
Coding-Hint
-
Use additional external cause code (Chapter XX), if desired, to
identify toxic agent.
-
Incl.:
-
Periodic paralysis (familial):
-
hyperkalaemic
-
hypokalaemic
-
myotonic
-
normokalaemic
G72.4
Inflammatory myopathy, not elsewhere classified
G72.8
Other specified myopathies
G72.9
Myopathy, unspecified
G73*
Disorders
of myoneural junction and muscle in diseases classified
elsewhere
G73.0*
Myasthenic syndromes in endocrine diseases
-
Incl.:
-
Myasthenic syndromes in:
G73.3*
Myasthenic syndromes in other diseases classified
elsewhere
G73.4*
Myopathy in infectious and parasitic diseases
classified elsewhere
G73.5*
Myopathy in endocrine diseases
-
Incl.:
-
Myopathy in:
-
Thyrotoxic myopathy (E05.-†)
G73.6*
Myopathy in metabolic diseases
-
Incl.:
-
Myopathy in:
-
glycogen storage disease (E74.0†)
-
lipid storage disorders (E75.-†)
G73.7*
Myopathy in other diseases classified elsewhere
-
Incl.:
-
Myopathy in: